- Home
- DVA
DVA
DaVita Inc.
as of 01-30-2026 3:52pm EST
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
Upcoming Earnings Alert:
Get ready for potential market movements as DaVita Inc. (DVA) prepares to release earnings report on 02 Feb 2026.
| Founded: | 1994 | Country: | United States |
| Employees: | N/A | City: | DENVER |
| Market Cap: | 8.2B | IPO Year: | 1995 |
| Target Price: | $145.00 | AVG Volume (30 days): | 898.6K |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 9.76 | EPS Growth: | 5.63 |
| 52 Week Low/High: | $101.00 - $179.60 | Next Earning Date: | 02-02-2026 |
| Revenue: | $13,317,965,000 | Revenue Growth: | 5.14% |
| Revenue Growth (this year): | 6.5% | Revenue Growth (next year): | 2.97% |
AI-Powered DVA Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare DVA vs Leading Stocks
See how DVA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "DVA DaVita Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.